Germany· DE-A57-52dd1bc19d116064
Toctino
A medicinal product containing alitretinoin, registered in Germany by Glaxosmithkline Gmbh & Co. Kg.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Alitretinoin
- Manufacturer
- Glaxosmithkline Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alitretinoin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAlipalmtin 10 mg zachte capsulesOrifarm Healthcare A/S
- United KingdomAlitretinoin 10mg capsulesEnnogen Healthcare International Ltd
- SwitzerlandAlitrecutan
- SwedenAlitretinoin Ebb 10 mg Kapsel, mjukEbb Medical AB
- NorwayAlitretinoin OrifarmOrifarm Generics A/S
- FinlandAlitretinoin OrifarmOrifarm Generics A/S
- SpainALITRETINOINA IFC 10 MG CAPSULAS BLANDAS EFGIndustrial Farmaceutica Cantabria S.A.
- FranceALIZEM 10 mg, capsule mollePIERRE FABRE MEDICAMENT
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Alitretan, Toctino
- Belgium · Alitretinoin Orifarm
- Denmark · Alitretinoin Orifarm, Toctino
- Spain · Alitretinoína Ifc, Toctino
- Finland · Alitretinoin Orifarm, Toctino
- France · Alizem, Toctino
- United Kingdom (Northern Ireland) · Alitretinoin Ennogen Healthcare, Alitretinoin Ennogen Ip
- Italy · Alitrecare, Toctino
- Netherlands · Alipalmtin, Alitretinoïne Ifc
- Norway · Alitretinoin Orifarm, Toctino
- Portugal · Alitretinoína Cantabria
- Sweden · Alitretinoin Orifarm
- Slovenia · Toctino
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e975dedc-98c0-4ad5-a1be-60286a33481f GET /v1/drugs/e975dedc-98c0-4ad5-a1be-60286a33481f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Alitretinoin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about alitretinoin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.